Found 23 matching trials
Phase III Confirmatory Study in Erythropoietic Protoporphyria
PHASE3This is a randomized placebo-controlled study to be conducted in two parall...
Location
University of Alabama
Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients
PHASE1The purpose of this study is to evaluate the concentration of afamelanotide...
Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)
PHASE1The purpose of this study is to look at the efficacy of afamelanotide, when...
Location
Henry Ford Medical Center
Phase II Solar Urticaria (SU) Pilot Study
PHASE2Urticaria is one of the most common dermatological conditions with diverse ...
Location
Salford Royal Foundation Hospital (Hope Hospital)
Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo
PHASE2The purpose of this study is to determine whether afamelanotide and narrow ...
Location
Multiple Locations
Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE)
N/AThe purpose of this study is to determine whether the afamelanotide (CUV164...
Location
St Vincents Hospital
A Safety Extension Study in Patients With Erythropoietic Protoporphyria (EPP)
PHASE3The main objectives of the study were to evaluate the safety and tolerabili...
Location
Multiple Locations
Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)
PHASE3Afamelanotide is a man-made drug being studied for use as a preventative me...
Location
HUS:n Iho-ja allergiasairaala (Skin and Allergy Hospital)
Implant Pharmacokinetic and Pharmacodynamic Study
PHASE1This is a single center, pharmacokinetic and pharmacodynamic study in healt...
Location
Prism Research Inc.
Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Variegate Porphyria (VP)
PHASE2The primary objective is to evaluate the impact of afamelanotide on the sev...
Location
CLINUVEL investigational site